600511 国药股份
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)8.48612.15714.31114.55114.482
总资产报酬率 ROA (%)4.2605.9376.9166.8176.630
投入资产回报率 ROIC (%)6.7599.45311.29411.48711.621

边际利润分析
销售毛利率 (%)6.3457.1068.0318.4017.814
营业利润率 (%)4.9405.2925.9255.9235.267
息税前利润/营业总收入 (%)4.8685.1105.6445.8445.222
净利润/营业总收入 (%)3.9514.2094.6974.6794.150

收益指标分析
经营活动净收益/利润总额(%)81.35182.66385.36584.82886.605
价值变动净收益/利润总额(%)22.80518.69012.61610.84911.590
营业外收支净额/利润总额(%)-0.610-0.897-0.460-0.262-0.101

偿债能力分析
流动比率 (X)2.1502.0432.0352.0221.930
速动比率 (X)1.7861.7101.7501.7311.654
资产负债率 (%)43.25845.67445.97446.43748.749
带息债务/全部投入资本 (%)11.88419.17815.01216.49814.208
股东权益/带息债务 (%)702.781396.060531.600472.573563.460
股东权益/负债合计 (%)118.745107.364105.737103.38493.595
利息保障倍数 (X)-115.644-38.006-22.238-92.200-132.292

营运能力分析
应收账款周转天数 (天)96.04575.73753.26045.32643.226
存货周转天数 (天)37.03734.14930.24231.23727.584